Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ADVM Adverum Biotechnologies, Inc. daily Stock Chart
ADVM [NASD]
Adverum Biotechnologies, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.05 Insider Own11.22% Shs Outstand66.47M Perf Week-49.48%
Market Cap418.10M Forward P/E- EPS next Y-1.12 Insider Trans0.27% Shs Float56.21M Perf Month-49.56%
Income-66.10M PEG- EPS next Q-0.26 Inst Own85.50% Short Float16.56% Perf Quarter-45.35%
Sales0.90M P/S464.55 EPS this Y-12.40% Inst Trans15.16% Short Ratio5.37 Perf Half Y11.33%
Book/sh2.79 P/B2.25 EPS next Y-9.80% ROA-30.40% Target Price7.75 Perf Year2.28%
Cash/sh2.67 P/C2.35 EPS next 5Y- ROE-33.80% 52W Range2.62 - 16.38 Perf YTD99.68%
Dividend- P/FCF- EPS past 5Y-36.80% ROI-38.20% 52W High-61.61% Beta2.42
Dividend %- Quick Ratio17.80 Sales past 5Y27.40% Gross Margin- 52W Low140.08% ATR1.24
Employees73 Current Ratio17.80 Sales Q/Q- Oper. Margin- RSI (14)28.74 Volatility24.74% 11.69%
OptionableYes Debt/Eq0.00 EPS Q/Q22.20% Profit Margin- Rel Volume1.91 Prev Close5.78
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout- Avg Volume1.73M Price6.29
Recom2.70 SMA20-42.30% SMA50-49.47% SMA200-16.39% Volume3,308,195 Change8.82%
Sep-13-19Reiterated Chardan Capital Markets Neutral $10 → $6
Jun-14-19Resumed Raymond James Mkt Perform
Nov-02-18Downgrade SunTrust Buy → Hold
Nov-02-18Downgrade Raymond James Outperform → Mkt Perform
Sep-21-18Initiated Cantor Fitzgerald Overweight
Aug-30-18Initiated SunTrust Buy $11
Feb-15-18Resumed Piper Jaffray Overweight $12
Oct-12-17Initiated Raymond James Outperform $6
Sep-13-19 12:29PM  A Look At Benzinga Pro's Most-Searched Tickers For September 13, 2019 Benzinga
10:06AM  Adverum Reports Data From Phase I Wet AMD Study, Stock Down Zacks
Sep-12-19 11:30AM  Adverum Shares Sink After Phase 1 Readout From Wet AMD Gene Therapy Trial Benzinga -50.33%
07:38AM  The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study Benzinga
02:41AM  Adverum Biotechnologies Reports Positive 24-Week Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD GlobeNewswire
Sep-04-19 04:01PM  Adverum Biotechnologies to Host a Conference Call and Webcast to Present 24-week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at Retina Society 2019 Annual Meeting GlobeNewswire +9.24%
08:58AM  The Keys to Successfully Timing the Markets - September 04, 2019 Zacks
Aug-28-19 04:01PM  Adverum Biotechnologies to Present 24-Week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October GlobeNewswire
Aug-27-19 11:36AM  Is the Options Market Predicting a Spike in Adverum Biotechnologies (ADVM) Stock? Zacks
Aug-16-19 11:23AM  What's in Store for Aytu BioScience's (AYTU) Q4 Earnings? Zacks +7.46%
Aug-15-19 08:45PM  Edited Transcript of ADVM earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
09:57AM  The Keys to Successful Timing the Markets - August 15, 2019 Zacks
Aug-09-19 08:49PM  Adverum Biotechnologies, Inc. (ADVM) Q2 2019 Earnings Call Transcript Motley Fool -6.17%
Aug-08-19 05:15PM  Adverum Biotechnologies (ADVM) Reports Q2 Loss, Lags Revenue Estimates Zacks +5.21%
04:00PM  Adverum Biotechnologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-06-19 09:54AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks +6.86%
Aug-02-19 11:25AM  Tenet Healthcare (THC) Q2 Earnings: What's in the Cards? Zacks -12.61%
Aug-01-19 04:00PM  Adverum Biotechnologies Announces Board and Senior Management Changes GlobeNewswire
10:33AM  Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Jul-31-19 09:12AM  2 Top Stocks to Buy in August Motley Fool
Jul-26-19 08:44AM  Is the Options Market Predicting a Spike in Adverum (ADVM) Stock? Zacks
Jul-25-19 04:00PM  Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2019 Financial Results and Provide Corporate Updates GlobeNewswire -7.87%
Jul-16-19 09:00AM  What Makes Adverum Biotechnologies (ADVM) a New Strong Buy Stock Zacks
Jul-15-19 04:00PM  Adverum Biotechnologies Appoints Senior Leaders GlobeNewswire
Jul-13-19 08:00AM  3 Top Growth Stocks to Buy Right Now Motley Fool
Jul-12-19 07:15AM  5 Best Biotech Stocks of 2019 So Far Motley Fool
Jul-11-19 08:58AM  Adverum (ADVM) Jumps: Stock Rises 5.1% Zacks
Jul-08-19 07:58AM  Adverum Biotechnologies to Present Data at Upcoming Conferences GlobeNewswire +22.53%
Jul-02-19 10:15AM  3 Biotechs That Have Doubled This Year (Acquisition Next?) Motley Fool
Jun-26-19 02:34PM  Did Hedge Funds Drop The Ball On Adverum Biotechnologies, Inc. (ADVM) ? Insider Monkey
Jun-23-19 09:28AM  The Adverum Biotechnologies (NASDAQ:ADVM) Share Price Has Gained 252%, So Why Not Pay It Some Attention? Simply Wall St.
Jun-10-19 09:00AM  Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD GlobeNewswire
May-24-19 09:44AM  Adverum Biotechnologies, Inc. (ADVM) Shares March Higher, Can It Continue? Zacks
May-22-19 11:34AM  Biotech Stock Roundup: Label Expansion for CELG's Drugs, Setback for IMGN Zacks
May-20-19 04:14PM  Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study Zacks
May-19-19 09:00AM  3 Biotech Stocks That Soared Last Week: Are They Buys? Motley Fool
May-17-19 08:00PM  Tallgrass Energy Barrons.com +11.32%
09:00AM  All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy Zacks
08:03AM  The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering Benzinga
May-16-19 09:00AM  Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022 in Wet AMD GlobeNewswire +26.05%
May-11-19 02:36AM  Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? Zacks
May-10-19 03:45PM  Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? Zacks
May-08-19 05:15PM  Adverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue Estimates Zacks -5.45%
04:08PM  Adverum Biotechnologies: 1Q Earnings Snapshot Associated Press
04:00PM  Adverum Biotechnologies Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
11:39AM  Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store? Zacks
May-02-19 04:30PM  Adverum Biotechnologies Announces Board Changes GlobeNewswire
06:00AM  Adverum Biotechnologies to Present 30-month Preclinical Safety and Expression Data for ADVM-022 Gene Therapy in Wet AMD at the ASGCT 22nd Annual Meeting GlobeNewswire
May-01-19 10:33AM  Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-30-19 01:30PM  Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting GlobeNewswire
Apr-28-19 10:50PM  Is a Beat in the Offing for Humana's (HUM) Q1 Earnings? Zacks
Apr-25-19 07:58AM  The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings Benzinga
Apr-24-19 04:00PM  Adverum Biotechnologies Appoints Thomas Leung as Chief Financial Officer GlobeNewswire
Apr-17-19 07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 04:00PM  Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO GlobeNewswire
Apr-15-19 09:00AM  Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD GlobeNewswire +11.57%
Apr-05-19 12:25PM  What Kind Of Shareholders Own Adverum Biotechnologies, Inc. (NASDAQ:ADVM)? Simply Wall St.
Apr-01-19 04:01PM  Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Aaron Osborne, MBBS MRCOphth, as Chief Medical Officer GlobeNewswire
Mar-18-19 09:00AM  Adverum Biotechnologies to Participate in Upcoming Conferences GlobeNewswire +5.02%
Mar-12-19 10:50AM  Adverum Biotechnologies (ADVM) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-06-19 04:10PM  Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Feb-28-19 04:10PM  Adverum to Present at the Cowen 39th Annual Health Care Conference GlobeNewswire -7.32%
Feb-13-19 04:10PM  Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-11-19 08:30AM  Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference GlobeNewswire +5.71%
Jan-30-19 07:30AM  Report: Developing Opportunities within Waste Connections, Performance Food Group, HealthEquity, PS Business Parks, Adverum Biotechnologies, and Bellicum Pharmaceuticals Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-06-19 08:00PM  Adverum Biotechnologies Provides 2019 Outlook GlobeNewswire
Dec-20-18 08:30AM  Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire -6.41%
Dec-12-18 04:32AM  What Bargains? Play 5 Stocks With Rising P/E Instead Zacks
01:09AM  Is Adverum Biotechnologies, Inc. (ADVM) A Good Stock To Buy? Insider Monkey
Dec-03-18 04:10PM  Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources GlobeNewswire
08:30AM  Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy GlobeNewswire
Nov-19-18 08:30AM  Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration GlobeNewswire
Nov-13-18 04:30PM  Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-08-18 08:30PM  Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:30PM  Adverum Biotechnologies: 3Q Earnings Snapshot Associated Press
04:10PM  Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
07:50AM  Investor Expectations to Drive Momentum within Consolidated Edison, MUELLER WATER PRODUCTS, Adverum Biotechnologies, Buckeye Partners, inTest, and Live Nation Entertainment Discovering Underlying Factors of Influence GlobeNewswire
Nov-07-18 10:30AM  Adverum Biotechnologies (ADVM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-02-18 03:12PM  Here's Why Adverum Biotechnologies Dropped as Much as 42.4% Today Motley Fool -26.59%
12:15PM  Apple, Cirrus Logic, GoPro, and More: Heres Why These Stocks Are On the Move Insider Monkey
08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
Nov-01-18 04:15PM  Adverum Biotechnologies Provides Program Updates GlobeNewswire +8.33%
Oct-18-18 07:56AM  The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Benzinga -6.75%
Oct-17-18 04:10PM  Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors GlobeNewswire
09:00AM  Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT) GlobeNewswire
Oct-16-18 08:40AM  Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou Fundamental Analysis, Key Performance Indications GlobeNewswire
Sep-21-18 03:32PM  Cantor Fitzgerald's 7 Buys For 7 Biotechs Benzinga
Sep-20-18 09:02AM  The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut Benzinga
Sep-19-18 06:36PM  Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD GlobeNewswire
Sep-18-18 04:10PM  Adverum to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-06-18 10:46AM  Why Adverum Biotechnologies (ADVM) is a Top Pick for Momentum Investors Zacks -9.03%
Sep-04-18 10:07AM  Zacks.com highlights: American Woodmark, Adverum Biotechnologies, Merrimack Pharmaceuticals, Athene Holding and M&T Bank Zacks -7.89%
Aug-31-18 04:17AM  Can The Uptrend Continue for Adverum Biotechnologies (ADVM)? Zacks +6.29%
Aug-29-18 05:30PM  Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration GlobeNewswire
Aug-23-18 11:39AM  7 Cheap Biotech Stocks to Buy Now InvestorPlace
Aug-20-18 08:25AM  Investor Expectations to Drive Momentum within Mazor Robotics, Kinross Gold, Mimecast, DBV Technologies S.A., Adamas Pharmaceuticals, and Adverum Biotechnologies Discovering Underlying Factors of Influence GlobeNewswire
Aug-08-18 07:45PM  Adverum Biotechnologies: 2Q Earnings Snapshot Associated Press
04:05PM  Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Aug-01-18 04:05PM  Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline GlobeNewswire
Jul-31-18 12:17PM  What's in Store for Adverum (ADVM) This Earnings Season? Zacks
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was founded in 2006 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scopa James PaulDirectorMay 06Buy6.7120,000134,20020,000May 06 07:42 PM
open in yahoo | open in reuters | open in google